文献速递心血管MR

场强对临床心脏磁共振成像的影响

Impact of Field Strength in Clinical Cardiac Magnetic Resonance Imaging.
PubMed 文献 · Invest Radiol · 2021-01-01

该综述比较了1.5 T与3 T场强在心脏MRI中的物理差异及其对功能成像、水肿成像、延迟强化、首过灌注、心肌标测和相位对比血流成像等常规应用的影响,讨论了各场强的优势与局限,并提供了克服局限的方案及未来场强推荐。

要点

  • 1.5 T与3 T在心脏MRI中各有优势与局限,不存在适用于所有应用的理想场强。
  • 3 T在信噪比和组织对比度方面有优势,但面临挑战影响其临床广泛应用。
  • 针对不同心脏MRI应用,需根据场强特点选择序列并采取相应解决方案。

核心结论

  • 对于心脏MRI,没有一种理想的场强适用于所有临床应用,1.5 T和3 T各有其优势与局限。

研究设计与样本

  • 综述,描述了1.5 T与3 T的物理差异及其对主要常规心脏MRI应用的影响,未报告检索范围与纳入文献数量。

临床应用与阅片要点

  • 日常阅片和报告时应了解1.5 T与3 T在功能成像、水肿成像、延迟强化、首过灌注、心肌标测和相位对比血流成像中的优势与局限,并注意采取相应解决方案克服潜在局限。

局限性

  • 为综述性文章,未报告系统检索策略与纳入文献数量,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiac magnetic resonance imaging (MRI) is widely applied for the noninvasive assessment of cardiac structure and function, and for tissue characterization. For more than 2 decades, 1.5 T has been considered the field strength of choice for cardiac MRI. Although the number of 3-T systems significantly increased in the past 10 years and numerous new developments were made, challenges seem to remain that hamper a widespread clinical use of 3-T MR systems for cardiac applications. As the number of clinical cardiac applications is increasing, with each having their own benefits at both field strengths, no "holy grail" field strength exists for cardiac MRI that one should ideally use. This review describes the physical differences between 1.5 and 3 T, as well as the effect of these differences on major (routine) cardiac MRI applications, including functional imaging, edema imaging, late gadolinium enhancement, first-pass stress perfusion, myocardial mapping, and phase contrast flow imaging. For each application, the advantages and limitations at both 1.5 and 3 T are discussed. Solutions and alternatives are provided to overcome potential limitations. Finally, we briefly elaborate on the potential use of alternative field strengths (ie, below 1.5 T and above 3 T) for cardiac MRI and conclude with field strength recommendations for the future of cardiac MRI.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Holtackers RJ, Wildberger JE, Wintersperger BJ, et al. Impact of Field Strength in Clinical Cardiac Magnetic Resonance Imaging. Invest Radiol. 2021. PMID: 34261084. doi:10.1097/RLI.0000000000000809

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。